Events
-
-
Investor Conference with ØU Life Science
Symbion, Fruebjergvej 3, 2100 CopenhagenMagnus Corfitzen will present at the ØU Life Science conference. To register: Investor event - 26 March
-
-
Interview with Carnegie
Interview with Magnus Corfitzen, to join the live event: Ascelia Pharma - Interview
-
-
Investor day at ABG Sundall Collier
At Six, Brunkebergstorg 6, StockholmMagnus Corfitzen, CEO will be presenting at ABG Sundall Collier.
-
Presentation of Q1 2025 with HC Andersen
Julie Waras Brogren, Deputy CEO will present the Q1 2025 results. To register: First quarter 2025
-
-
Presentation of H1 2025 Results with HC Andersen
Ascelia Pharma will present the financial results for H1 2025. To register: H1 2025 results - 22 August at 10:00
-
-
BioPorto & Ascelia Pharma invite you to an event focusing on Nordic life-science equities.
The Auditorium, Tuborg Havnevej 15, st., Hellerup, DenmarkInvitation to investor event: Market trends in Nordic healthcare equities – featuring presentations by DNB Carnegie, BioPorto Diagnostics A/S & Ascelia Pharma AB Niels Granholm-Leth, Head of Equity Research DNB Carnegie will open the event with an overview of trends and performance in Nordic healthcare equities. Julie Waras Brogren, Deputy CEO, presents Ascelia Pharma and, […]
-
-
Presentation of Q3 2025 with HC Andersen
Deputy CEO Julie Waras Brogren will present the Q3 2025 results at a virtual live event for investors. To register: Q3 2025 presentation
-
Small Cap Day at DNB Carnegie
Magnus Corfitzen, CEO at Ascelia Pharma will be presenting at the Small Cap Day at DNB Carnegie. The event will take place at DNB Carnegie Hall in Stockholm, with both physical attendance and livestreaming: Small Cap Day - DNB Carnegie
-
-
Redeye Life Science Day
Redeye, Mäster Samuelsgatan 42, StockholmAndreas Norlin, Chief Scientific Officer will be presenting at Redeye Life Science day in Stockholm. You can already submit your questions: Redeye - Ascelia Pharma
-
Investor day with ABG Sundal Collier
Hotel At Six, StockholmMagnus Corfitzen will present at ABGSC’s Investor Days Seminar on December 4.
-
-
Redeye Fight Cancer 2026
Magnus Corfitzen will participate at the Redeye Fight Cancer 2026 on January 21. To join the live presentation: Click here
-
-
Presentation of full-year report 2025 with H C Andersen
Magnus Corfitzen will present the full-year financial results for 2025 at a virtual live event To register for the presentation and submit questions in advance: Ascelia Pharma - Full Year Report 2025
-
-
Digital Healthcare Seminar with DNB Carnegie
Magnus Corfitzen will be presenting at the healthcare seminar, to register: Registration
-
DNB Carnegie Micro Cap Event
Malmö High Court Malmohusvagen 1, MalmöMagnus Corfitzen will present in person at the Micro Cap Event.
-
-
Healthcare day with Redeye
Magnus Corfitzen will be presenting at the Healthcare Day in Stockholm. To register: Redeye Healthcare Day 2026
-
Investor Seminar with HC Andersen (in Danish)
Matrikel 1, Højbro Pl. 10 – 1200, Copenhagen , DenmarkMagnus Corfitzen will be presenting in Copenhagen. To register: click here
-
-
Presentation of Q1 2026 results with HC Andersen
Magnus Corfitzen will present the Q1 2026 results. Direct registration via link: Ascelia Pharma Presentation
-
Investor Day with ABG in Stockholm
Magnus Corfitzen will present at the investor day in Stockholm. To join the session live: Investor Day